CyberArk Software - CYBR Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $297.84
  • Forecasted Upside: 0.86%
  • Number of Analysts: 25
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 24 Buy Ratings
  • 0 Strong Buy Ratings
$295.30
▲ +0.84 (0.29%)

This chart shows the closing price for CYBR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CyberArk Software Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CYBR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CYBR

Analyst Price Target is $297.84
▲ +0.86% Upside Potential
This price target is based on 25 analysts offering 12 month price targets for CyberArk Software in the last 3 months. The average price target is $297.84, with a high forecast of $330.00 and a low forecast of $220.00. The average price target represents a 0.86% upside from the last price of $295.30.

This chart shows the closing price for CYBR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 25 polled investment analysts is to moderate buy stock in CyberArk Software. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 17 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/20/2023
  • 0 strong buy ratings
  • 18 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/19/2023
  • 0 strong buy ratings
  • 19 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/17/2023
  • 0 strong buy ratings
  • 22 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/15/2024
  • 0 strong buy ratings
  • 23 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/14/2024
  • 0 strong buy ratings
  • 23 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/13/2024
  • 0 strong buy ratings
  • 23 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/11/2024
  • 0 strong buy ratings
  • 24 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/11/2024

Latest Recommendations

  • 0 strong buy ratings
  • 24 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/9/2024BTIG ResearchBoost TargetBuy ➝ Buy$310.00 ➝ $325.00
10/7/2024BarclaysBoost TargetOverweight ➝ Overweight$315.00 ➝ $330.00
10/1/2024WedbushBoost TargetOutperform ➝ Outperform$300.00 ➝ $325.00
9/24/2024Jefferies Financial GroupBoost TargetBuy ➝ Buy$315.00 ➝ $330.00
9/20/2024Royal Bank of CanadaInitiated CoverageOutperform$328.00
8/9/2024CitigroupBoost TargetBuy ➝ Buy$305.00 ➝ $310.00
8/9/2024DA DavidsonBoost TargetBuy ➝ Buy$285.00 ➝ $315.00
8/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$300.00 ➝ $300.00
8/9/2024WedbushBoost TargetOutperform ➝ Outperform$285.00 ➝ $300.00
8/9/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$310.00 ➝ $310.00
8/9/2024KeyCorpBoost TargetOverweight ➝ Overweight$300.00 ➝ $310.00
8/9/2024SusquehannaBoost TargetPositive ➝ Positive$310.00 ➝ $320.00
8/9/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$295.00 ➝ $315.00
8/6/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$310.00 ➝ $310.00
7/22/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$300.00 ➝ $300.00
7/11/2024BarclaysBoost TargetOverweight ➝ Overweight$280.00 ➝ $315.00
6/25/2024GuggenheimReiterated RatingBuy ➝ Buy$300.00 ➝ $300.00
6/21/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$300.00 ➝ $300.00
6/17/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$310.00 ➝ $310.00
6/4/2024Canaccord Genuity GroupLower TargetBuy ➝ Buy$300.00 ➝ $280.00
5/24/2024JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$280.00 ➝ $310.00
5/22/2024DA DavidsonBoost TargetBuy ➝ Buy$275.00 ➝ $285.00
5/20/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$310.00 ➝ $310.00
5/14/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$280.00
5/3/2024DA DavidsonLower TargetBuy ➝ Buy$300.00 ➝ $275.00
5/3/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$300.00
5/3/2024WedbushReiterated RatingOutperform ➝ Outperform$285.00
5/3/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$310.00
5/1/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$310.00 ➝ $310.00
4/24/2024Bank of AmericaReiterated RatingBuy ➝ Buy$315.00
4/17/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$300.00
3/28/2024BTIG ResearchInitiated CoverageBuy$317.00
3/15/2024Bank of AmericaBoost TargetBuy ➝ Buy$300.00 ➝ $315.00
2/29/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$300.00
2/9/2024Truist FinancialBoost TargetBuy ➝ Buy$250.00 ➝ $300.00
2/9/2024MizuhoBoost TargetBuy ➝ Buy$250.00 ➝ $310.00
2/9/2024SusquehannaBoost TargetPositive ➝ Positive$255.00 ➝ $310.00
2/9/2024KeyCorpBoost TargetOverweight ➝ Overweight$274.00 ➝ $305.00
2/9/2024Needham & Company LLCBoost TargetBuy ➝ Buy$245.00 ➝ $310.00
2/9/2024Rosenblatt SecuritiesBoost TargetBuy ➝ Buy$265.00 ➝ $300.00
2/8/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$210.00 ➝ $300.00
1/31/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$210.00
1/31/2024JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$195.00 ➝ $280.00
1/30/2024KeyCorpBoost TargetOverweight ➝ Overweight$265.00 ➝ $274.00
1/29/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$250.00 ➝ $275.00
1/18/2024KeyCorpBoost TargetOverweight ➝ Overweight$210.00 ➝ $265.00
1/16/2024Truist FinancialBoost TargetBuy ➝ Buy$210.00 ➝ $250.00
1/10/2024CitigroupBoost TargetBuy ➝ Buy$215.00 ➝ $265.00
1/10/2024UBS GroupBoost TargetBuy ➝ Buy$215.00 ➝ $260.00
1/10/2024Rosenblatt SecuritiesBoost TargetBuy ➝ Buy$215.00 ➝ $265.00
1/9/2024Morgan StanleyDowngradeOverweight ➝ Equal Weight$195.00 ➝ $240.00
1/8/2024OppenheimerBoost TargetOutperform ➝ Outperform$195.00 ➝ $260.00
12/15/2023SusquehannaInitiated CoveragePositive$255.00
12/15/2023Jefferies Financial GroupInitiated CoverageBuy$240.00
12/11/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$207.00 ➝ $248.00
12/4/2023Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$166.00 ➝ $250.00
11/3/2023Rosenblatt SecuritiesBoost TargetBuy ➝ Buy$195.00 ➝ $215.00
11/3/2023MizuhoBoost TargetBuy ➝ Buy$175.00 ➝ $195.00
11/3/2023Truist FinancialBoost TargetBuy ➝ Buy$185.00 ➝ $210.00
11/3/2023StephensBoost TargetOverweight ➝ Overweight$210.00 ➝ $220.00
11/3/2023WedbushBoost TargetOutperform ➝ Outperform$185.00 ➝ $200.00
11/3/2023Morgan StanleyBoost TargetOverweight ➝ Overweight$180.00 ➝ $195.00
11/3/2023KeyCorpBoost TargetOverweight ➝ Overweight$196.00 ➝ $210.00
11/2/2023Needham & Company LLCBoost TargetBuy ➝ Buy$190.00 ➝ $220.00
10/24/2023JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$195.00
10/17/2023JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$182.00 ➝ $200.00
9/20/2023Bank of AmericaBoost Target$187.00 ➝ $198.00
9/18/2023WedbushReiterated RatingOutperform ➝ Outperform$185.00
9/12/2023WedbushReiterated RatingOutperform ➝ Outperform$185.00
9/7/2023GuggenheimInitiated CoverageBuy$200.00
8/29/2023CitigroupBoost TargetBuy ➝ Buy$180.00 ➝ $190.00
8/24/2023Canaccord Genuity GroupBoost TargetBuy ➝ Buy$185.00 ➝ $195.00
8/11/2023JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$175.00 ➝ $182.00
8/11/2023Rosenblatt SecuritiesBoost Target$185.00 ➝ $195.00
8/11/2023DA DavidsonBoost TargetBuy ➝ Buy$185.00 ➝ $200.00
8/11/2023StephensBoost TargetOverweight ➝ Overweight$180.00 ➝ $210.00
8/11/2023Morgan StanleyBoost TargetOverweight ➝ Overweight$173.00 ➝ $180.00
8/11/2023Canaccord Genuity GroupBoost TargetBuy ➝ Buy$174.00 ➝ $185.00
8/11/2023Needham & Company LLCBoost TargetBuy ➝ Buy$185.00 ➝ $190.00
8/11/2023OppenheimerBoost TargetOutperform ➝ Outperform$180.00 ➝ $195.00
8/11/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$140.00 ➝ $155.00
8/11/2023KeyCorpBoost TargetOverweight ➝ Overweight$194.00 ➝ $196.00
8/11/2023BarclaysBoost TargetOverweight ➝ Overweight$178.00 ➝ $180.00
8/10/2023Wolfe ResearchBoost TargetOutperform ➝ Outperform$165.00 ➝ $175.00
8/10/2023Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$185.00
8/2/2023KeyCorpBoost TargetOverweight ➝ Overweight$189.00 ➝ $194.00
7/18/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$180.00
5/25/2023Bank of AmericaBoost Target$175.00 ➝ $187.00
5/12/2023BarclaysBoost Target$175.00 ➝ $178.00
5/1/2023Rosenblatt SecuritiesInitiated CoverageBuy$175.00
4/21/2023Truist FinancialInitiated CoverageBuy$185.00
4/13/2023BarclaysBoost TargetOverweight$158.00 ➝ $175.00
2/10/2023CitigroupBoost TargetBuy$155.00 ➝ $175.00
2/10/2023Canaccord Genuity GroupBoost TargetBuy$165.00 ➝ $174.00
2/10/2023Needham & Company LLCReiterated RatingBuy$180.00
2/10/2023MizuhoReiterated RatingBuy$175.00
2/10/2023DA DavidsonBoost TargetBuy$175.00 ➝ $185.00
2/10/2023Morgan StanleyBoost TargetOverweight$160.00 ➝ $173.00
2/10/2023BarclaysBoost TargetOverweight$150.00 ➝ $158.00
2/9/2023Roth CapitalReiterated RatingBuy
1/24/2023Morgan StanleyLower TargetOverweight$162.00 ➝ $160.00
1/24/2023JPMorgan Chase & Co.Initiated CoverageNeutral$147.00
1/20/2023MizuhoLower TargetBuy$185.00 ➝ $175.00
1/12/2023Morgan StanleyLower TargetOverweight$184.00 ➝ $162.00
1/11/2023BarclaysLower TargetOverweight$168.00 ➝ $150.00
1/5/2023Piper SandlerLower Target$190.00 ➝ $160.00
1/4/2023Sumitomo Mitsui Financial GroupInitiated CoverageNeutral$145.00
12/15/2022DA DavidsonInitiated CoverageNeutral ➝ Buy$175.00
11/16/2022KeyCorpLower TargetOverweight$190.00 ➝ $189.00
11/4/2022MizuhoBoost TargetBuy$180.00 ➝ $185.00
11/4/2022Needham & Company LLCBoost TargetBuy$175.00 ➝ $180.00
10/19/2022Robert W. BairdReiterated RatingOutperform$182.00
10/11/2022BarclaysBoost Target$175.00 ➝ $180.00
9/30/2022Canaccord Genuity GroupInitiated CoverageBuy
9/29/2022CowenInitiated CoverageOutperform$195.00
9/29/2022CowenInitiated CoverageOutperform
9/15/2022MKM PartnersInitiated CoverageBuy$190.00
9/8/2022Cantor FitzgeraldInitiated CoverageOverweight$180.00
8/12/2022Wolfe ResearchBoost TargetOutperform$155.00 ➝ $180.00
8/11/2022Morgan StanleyBoost TargetOverweight$172.00 ➝ $184.00
8/11/2022BarclaysBoost TargetOverweight$165.00 ➝ $175.00
8/11/2022The Goldman Sachs GroupBoost TargetNeutral$158.00 ➝ $175.00
8/11/2022WedbushBoost TargetOutperform$150.00 ➝ $170.00
8/11/2022KeyCorpBoost TargetOverweight$160.00 ➝ $184.00
8/11/2022Needham & Company LLCBoost TargetBuy$195.00 ➝ $200.00
8/11/2022Wells Fargo & CompanyBoost TargetEqual Weight$125.00 ➝ $145.00
8/11/2022MizuhoBoost TargetBuy$170.00 ➝ $180.00
7/19/2022MizuhoLower TargetBuy$180.00 ➝ $170.00
5/25/2022StephensInitiated CoverageOverweight$170.00
5/13/2022Stifel NicolausLower Target$210.00 ➝ $168.00
5/13/2022WedbushLower Target$195.00 ➝ $150.00
5/13/2022Wells Fargo & CompanyLower Target$170.00 ➝ $125.00
5/13/2022Robert W. BairdLower Target$200.00 ➝ $180.00
5/13/2022MizuhoLower Target$205.00 ➝ $180.00
5/12/2022Summit InsightsLower Target$225.00 ➝ $150.00
4/14/2022WedbushBoost TargetOutperform$180.00 ➝ $195.00
4/4/2022KeyCorpInitiated CoverageOverweight$217.00
3/30/2022Wells Fargo & CompanyBoost TargetEqual Weight$150.00 ➝ $170.00
2/22/2022JMP SecuritiesInitiated CoverageBuy$175.00
2/11/2022GuggenheimLower TargetBuy$225.00 ➝ $182.00
2/11/2022Wells Fargo & CompanyBoost TargetEqual Weight$140.00 ➝ $150.00
2/11/2022WedbushLower TargetOutperform$230.00 ➝ $180.00
2/11/2022Robert W. BairdLower TargetOutperform$225.00 ➝ $200.00
2/11/2022Morgan StanleyBoost TargetOverweight$186.00 ➝ $191.00
2/11/2022Needham & Company LLCUpgradeHold ➝ Buy$195.00
2/11/2022BarclaysBoost TargetOverweight$190.00 ➝ $215.00
2/11/2022MizuhoBoost TargetBuy$195.00 ➝ $205.00
1/24/2022CitigroupInitiated CoverageBuy$180.00
1/19/2022BarclaysLower TargetOverweight$230.00 ➝ $190.00
1/18/2022Morgan StanleyLower TargetOverweight$210.00 ➝ $186.00
1/18/2022MizuhoLower Target$220.00 ➝ $195.00
1/6/2022Piper SandlerLower Target$220.00 ➝ $200.00
11/5/2021The Goldman Sachs GroupBoost TargetNeutral$166.00 ➝ $190.00
11/5/2021MizuhoBoost TargetBuy$200.00 ➝ $220.00
11/5/2021BarclaysBoost TargetOverweight$200.00 ➝ $230.00
10/27/2021JMP SecuritiesBoost TargetOutperform$173.00 ➝ $214.00
10/18/2021MizuhoBoost TargetBuy$185.00 ➝ $200.00
10/13/2021BarclaysBoost TargetOverweight$180.00 ➝ $200.00
10/4/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$165.00
9/22/2021Colliers SecuritiesReiterated RatingBuy$200.00
8/30/2021WedbushBoost TargetOutperform$160.00 ➝ $200.00
8/13/2021Wolfe ResearchBoost TargetOutperform$185.00 ➝ $190.00
8/13/2021WedbushBoost TargetOutperform ➝ Outperform$150.00 ➝ $160.00
8/13/2021BarclaysBoost TargetOverweight$171.00 ➝ $180.00
8/13/2021Robert W. BairdBoost TargetOutperform$160.00 ➝ $170.00
8/13/2021Stifel NicolausBoost TargetBuy$160.00 ➝ $175.00
8/12/2021William BlairReiterated RatingOutperform
8/6/2021Wolfe ResearchInitiated CoverageOutperform$185.00
7/19/2021Colliers SecuritiesUpgradeNeutral ➝ Buy$165.00
7/9/2021Morgan StanleyReiterated RatingBuy$200.00
5/24/2021Stifel NicolausReiterated RatingBuy
5/7/2021The Goldman Sachs GroupLower TargetNeutral$176.00 ➝ $158.00
5/6/2021DA DavidsonLower Target$200.00 ➝ $175.00
5/6/2021WedbushLower TargetOutperform$185.00 ➝ $150.00
5/6/2021Monness Crespi & HardtLower TargetBuy$180.00 ➝ $165.00
5/6/2021Robert W. BairdLower TargetOutperform$170.00 ➝ $160.00
4/7/2021Robert W. BairdUpgradeNeutral ➝ Outperform$170.00
3/11/2021BarclaysBoost TargetOverweight$181.00 ➝ $185.00
3/11/2021Needham & Company LLCReiterated RatingHold
2/12/2021Colliers SecuritiesDowngradeBuy ➝ Neutral
2/12/2021Morgan StanleyBoost TargetOverweight$185.00 ➝ $200.00
2/12/2021MizuhoBoost TargetBuy$175.00 ➝ $185.00
1/29/2021UBS GroupUpgradeNeutral ➝ Buy
1/12/2021MizuhoBoost TargetBuy$123.00 ➝ $175.00
1/12/2021DA DavidsonUpgradeNeutral ➝ Buy$100.00 ➝ $180.00
1/8/2021Morgan StanleyBoost TargetOverweight$140.00 ➝ $185.00
1/6/2021BarclaysBoost TargetOverweight$118.00 ➝ $175.00
1/5/2021Piper SandlerBoost TargetOverweight$125.00 ➝ $180.00
1/4/2021Monness Crespi & HardtBoost TargetBuy$125.00 ➝ $183.00
11/11/2020DA DavidsonLower Target$115.00 ➝ $100.00
11/11/2020MizuhoLower TargetBuy$128.00 ➝ $123.00
11/11/2020BarclaysLower TargetOverweight$130.00 ➝ $118.00
9/15/2020BarclaysUpgradeEqual Weight ➝ Overweight$130.00
8/12/2020OppenheimerInitiated CoverageBuy$120.00
8/5/2020Morgan StanleyBoost TargetOverweight$125.00 ➝ $135.00
8/5/2020Monness Crespi & HardtBoost TargetBuy$120.00 ➝ $125.00
8/5/2020OppenheimerBoost TargetOutperform$115.00 ➝ $120.00
8/4/2020Needham & Company LLCInitiated CoverageHold
8/4/2020Robert W. BairdReiterated RatingHold$120.00
7/21/2020GuggenheimBoost TargetBuy$115.00 ➝ $128.00
7/14/2020Morgan StanleyBoost TargetOverweight$114.00 ➝ $125.00
7/6/2020Monness Crespi & HardtUpgradeNeutral ➝ Buy$120.00
5/14/2020DA DavidsonBoost Target$80.00 ➝ $85.00
5/14/2020JMP SecuritiesLower TargetMarket Outperform$125.00 ➝ $120.00
5/14/2020GuggenheimLower TargetBuy$134.00 ➝ $115.00
5/14/2020WedbushReiterated RatingBuy$120.00
5/14/2020BarclaysBoost TargetBuy ➝ Equal Weight$98.00 ➝ $109.00
5/14/2020MizuhoLower TargetBuy$120.00 ➝ $117.00
5/14/2020Morgan StanleyBoost TargetOverweight$110.00 ➝ $114.00
5/14/2020UBS GroupLower TargetNeutral$104.00 ➝ $94.00
5/14/2020Needham & Company LLCReiterated RatingHold
5/13/2020OppenheimerInitiated CoverageBuy$115.00
4/27/2020JMP SecuritiesLower TargetMarket Outperform$135.00 ➝ $125.00
4/21/2020CowenLower TargetOutperform$145.00 ➝ $115.00
4/14/2020BarclaysReiterated RatingHold$98.00
3/25/2020Morgan StanleyLower TargetOverweight$160.00 ➝ $110.00
3/24/2020The Goldman Sachs GroupInitiated CoverageNeutral$87.00
3/22/2020Piper SandlerUpgradeNeutral ➝ Overweight$125.00 ➝ $110.00
3/18/2020Robert W. BairdInitiated CoverageNeutral$85.00
2/13/2020UBS GroupLower TargetNeutral$128.00 ➝ $123.00
2/13/2020GuggenheimLower TargetBuy$155.00 ➝ $134.00
2/13/2020Needham & Company LLCDowngradeBuy ➝ Hold
1/14/2020First AnalysisDowngradeStrong-Buy ➝ Outperform$143.00 ➝ $154.00
1/13/2020DA DavidsonInitiated CoverageNeutral$125.00
1/13/2020Morgan StanleyBoost TargetOverweight$149.00 ➝ $160.00
11/8/2019Piper Sandler CompaniesInitiated CoverageNeutral$120.00
11/7/2019JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Buy$163.00 ➝ $163.00
11/6/2019WedbushReiterated RatingOutperform
11/6/2019Needham & Company LLCReiterated RatingBuy$145.00
11/4/2019Evercore ISISet TargetBuy$140.00
(Data available from 10/11/2019 forward)

News Sentiment Rating

1.01 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 19 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/15/2024
  • 15 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
4/14/2024
  • 22 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/14/2024
  • 29 very positive mentions
  • 27 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
6/13/2024
  • 26 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/13/2024
  • 24 very positive mentions
  • 21 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
8/12/2024
  • 22 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/11/2024
  • 30 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/11/2024

Current Sentiment

  • 30 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
CyberArk Software logo
CyberArk Software Ltd., together with its subsidiaries, develops, markets, and sells software-based identity security solutions and services in the United States, Europe, the Middle East, Africa, and internationally. Its solutions include Privileged Access Manager, which offers risk-based credential security and session; Vendor Privileged Access Manager combines Privileged Access Manager and Remote Access to provide secure access to third-party vendors; Dynamic Privileged Access, a SaaS solution that provides just-in-time access to Linux Virtual Machines; Endpoint Privilege Manager, a SaaS solution that secures privileges on the endpoint; and Secure Desktop, a solution that protects access to endpoints. The company also provides workforce identity, which offers adaptive multi-factor authentication (MFA), single sign-on, secure web sessions, workforce password management, application gateway, identity lifecycle management, and directory services; and customer identity services that provides authentication and authorization services, MFA, directory, and user management. In addition, it offers Secrets Manager Credential Providers to provide and manage the credentials used by third-party solutions; Conjur Enterprise and Conjur Cloud, which offers a secrets management solution for specific requirements; Secrets Hub, a centralized visibility and management platform; Cloud Security solutions; Identity Management solutions, including lifecycle management, identity flows, identity compliance, and directory services; and Secure Browser. The company serves financial services, manufacturing, insurance, healthcare, energy and utilities, transportation, retail, technology, and telecommunications industries; and government agencies. The company was incorporated in 1996 and is headquartered in Petah Tikva, Israel.
Read More

Today's Range

Now: $295.30
Low: $292.77
High: $299.03

50 Day Range

MA: $275.01
Low: $241.52
High: $294.46

52 Week Range

Now: $295.30
Low: $154.76
High: $299.03

Volume

336,902 shs

Average Volume

527,291 shs

Market Capitalization

$12.48 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Frequently Asked Questions

What sell-side analysts currently cover shares of CyberArk Software?

The following equities research analysts have issued research reports on CyberArk Software in the last year: Bank of America Co., Barclays PLC, BTIG Research, Canaccord Genuity Group Inc., Cantor Fitzgerald, Citigroup Inc., DA Davidson, Guggenheim, Jefferies Financial Group Inc., JMP Securities, JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Robert W. Baird, Rosenblatt Securities, Royal Bank of Canada, Stephens, Susquehanna, Truist Financial Co., UBS Group AG, Wedbush, and Wells Fargo & Company.
View the latest analyst ratings for CYBR.

What is the current price target for CyberArk Software?

25 Wall Street analysts have set twelve-month price targets for CyberArk Software in the last year. Their average twelve-month price target is $297.84, suggesting a possible upside of 0.9%. Barclays PLC has the highest price target set, predicting CYBR will reach $330.00 in the next twelve months. Stephens has the lowest price target set, forecasting a price of $220.00 for CyberArk Software in the next year.
View the latest price targets for CYBR.

What is the current consensus analyst rating for CyberArk Software?

CyberArk Software currently has 1 hold rating and 24 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CYBR.

What other companies compete with CyberArk Software?

How do I contact CyberArk Software's investor relations team?

CyberArk Software's physical mailing address is 9 Hapsagot St. Park Ofer B P.O. BOX 3143, PETACH-TIKVA L3, 4951040. The technology company's listed phone number is (723) 918-0000 and its investor relations email address is [email protected]. The official website for CyberArk Software is www.cyberark.com. Learn More about contacing CyberArk Software investor relations.